Related Experiment Video
Updated: Jul 12, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Schizophrenic patients in the family practice]
Michael Riedel1, Ilja Spellmann, Norbert Müller
1Klinik für Psychiatrie und Psychotherapie der Universität München. Riedel@med.uni-muenchen.de
MMW Fortschritte Der Medizin
|August 30, 2007
Summary
Antipsychotic medications are key for schizophrenia treatment, with newer options improving patient quality of life and adherence. However, negative symptoms remain a significant challenge in long-term care.
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience
- Clinical Psychology
Background:
- Antipsychotic therapy has been the primary treatment for schizophrenia for over 50 years.
- While crucial for acute phases, pharmacological treatments are complemented by psychotherapy and sociotherapy for maintenance and relapse prevention.
- Atypical antipsychotics offer personalized treatment with improved side effect profiles, enhancing patient quality of life and medication compliance.
Purpose of the Study:
- To review the role of antipsychotics in schizophrenia management.
- To highlight the benefits of atypical antipsychotics in patient care.
- To identify persistent challenges in treating schizophrenia, particularly negative symptoms.
Main Methods:
- Literature review of antipsychotic therapies for schizophrenia.
- Analysis of treatment strategies for acute and maintenance phases.
- Evaluation of atypical antipsychotics' efficacy and patient-centered benefits.
Main Results:
- Antipsychotics remain central to schizophrenia treatment, especially during acute episodes.
- Atypical antipsychotics demonstrate improved tolerability, quality of life, and adherence.
- Negative and chronic residual symptoms continue to pose significant therapeutic difficulties.
Conclusions:
- Current antipsychotic treatments, particularly atypical agents, offer significant advantages for schizophrenia management.
- Addressing negative symptoms requires further research and innovative therapeutic approaches.
- A multimodal approach combining pharmacotherapy with psychosocial interventions is essential for comprehensive schizophrenia care.
Related Concept Videos
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:22Personality Disorders: Paranoid and Schizoid
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
Paranoid Personality Disorder
Paranoid personality disorder is...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...